Patient preferences for pilonidal sinus treatments: A discrete choice experiment survey

被引:8
|
作者
Wickramasekera, Nyantara [1 ]
Strong, Emily [2 ]
Shackley, Philip [1 ]
Callaghan, Tia [2 ]
Lee, Matthew [3 ,4 ]
Hind, Daniel [2 ]
Brown, Steven [2 ,3 ]
机构
[1] Regent Court, Sch Hlth & Related Res, Sheffield, England
[2] Univ Sheffield, Clin Trials Res Unit, Regent Court, Sheffield, England
[3] Northern Gen Hosp, Dept Gen Surg, Sheffield, England
[4] Univ Sheffield, Med Sch, Dept Oncol & Metab, Sheffield, England
关键词
discrete choice experiment; patient preference; pilonidal sinus; shared decision making; HEALTH-CARE;
D O I
10.1111/codi.16482
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aim: A range of treatments are available for pilonidal sinus disease (PSD), each of which has a different risk/benefit profile. The aim of this study was to collect patient views on which interventions they would rather avoid and which outcomes they most value for PSD.Method: We conducted an online survey using the discrete choice experiment (DCE) method. The DCE task involved participants choosing the best treatment option when presented with a set of competing hypothetical treatment profiles. Participants with symptomatic PSD referred for elective surgery were recruited from 33 National Health Service trusts between 2020 and 2022. Collected DCE data were analysed using regression analyses.Results: In all, 111 participants completed the survey. In the overall group, low risk of infection/persistence was the most important characteristic when making a treatment decision (attribute importance score 70%), followed by treatments with shorter recovery time with an attribute importance score of 30%. The results demonstrated that patients are willing to accept trade-offs between treatment recovery time and risk of infection/persistence. Patients above 30 years old are willing to accept a higher chance of treatment failure in exchange for rapid treatment recovery (risk tolerance between 22.35 and 34.67 percentage points). Conversely, patients in the younger age groups were risk averse and were only willing to accept a small risk of 1.51-2.15 in exchange for a treatment with faster recovery time. All patient groups appear to the reject the excision and leave open technique due to the need for protracted nursing care.Conclusion: This study highlights the need for shared decision making when it comes to surgery for PSD.
引用
收藏
页码:984 / 994
页数:11
相关论文
共 50 条
  • [41] Quantifying preferences for urea cycle disorder treatments using a discrete choice experiment
    Edelblut, Josiah
    Skaar, Jeffrey R.
    Hilton, John
    Seibt, Matthew
    Martin, Kyle
    Hadker, Nandini
    Quartel, Adrian
    Steiner, Robert D.
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 506 - 517
  • [42] Clinician Preferences for Oxybate Treatment for Narcolepsy: Survey and Discrete Choice Experiment
    Anne Marie Morse
    Lois Krahn
    Julie Flygare
    Clete Kushida
    Michael J. Thorpy
    Amod Athavale
    Jennifer Gudeman
    Advances in Therapy, 2023, 40 : 3199 - 3216
  • [43] Clinician Preferences for Oxybate Treatment for Narcolepsy: Survey and Discrete Choice Experiment
    Morse, Anne Marie
    Krahn, Lois
    Flygare, Julie
    Kushida, Clete
    Thorpy, Michael J.
    Athavale, Amod
    Gudeman, Jennifer
    ADVANCES IN THERAPY, 2023, 40 (07) : 3199 - 3216
  • [44] A discrete choice experiment to determine UK patient preference for attributes of disease modifying treatments in Multiple Sclerosis
    Bottomley, Catherine
    Lloyd, Andrew
    Bennett, Gary
    Adlard, Nicholas
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (08) : 863 - 870
  • [45] Societal preferences for rheumatoid arthritis treatments: evidence from a discrete choice experiment
    Harrison, Mark
    Marra, Carlo
    Shojania, Kam
    Bansback, Nick
    RHEUMATOLOGY, 2015, 54 (10) : 1816 - 1825
  • [46] Patient Preferences for Treating "OFF" Episodes in Parkinson's Disease: A Discrete Choice Experiment
    Thach, Andrew
    Sutphin, Jessie
    Coulter, Joshua
    Leach, Colton
    Pappert, Eric
    Mansfield, Carol
    PATIENT PREFERENCE AND ADHERENCE, 2021, 15 : 1187 - 1196
  • [47] Patient preferences for adjuvant therapy in renal cell carcinoma: a discrete-choice experiment
    Calhoun, Shawna R.
    Vass, Caroline
    Myers, Kelley
    Imai, Kentaro
    Bussberg, Cooper
    Bhattacharya, Rituparna
    Pinto, Cathy Anne
    Poulos, Christine
    FUTURE ONCOLOGY, 2025, 21 (07) : 843 - 851
  • [48] Patient preferences on pen injectors for assisted reproductive technology: a discrete choice experiment in France
    Ranisavljevic, Noemie
    Yazbeck, Chadi
    Vaugon, Sabrina
    Nuyttens, Celine
    Bernard, Caroline
    Arcelin, Thelma
    Kirion, Justin
    Baffert, Sandrine
    Castello-Bridoux, Claire
    Luciani, Laura
    Marino, Patricia
    Grynberg, Michael
    EXPERT OPINION ON DRUG DELIVERY, 2024, 21 (12) : 1897 - 1908
  • [49] Patient Preferences for Medications in Managing Type 2 Diabetes Mellitus: A Discrete Choice Experiment
    Ozdemir, Semra
    Baid, Drishti
    Verghese, Naina R.
    Lam, Amanda Y. R.
    Lee, Phong Ching
    Lim, Adoree Y. Y.
    Zhu, Ling
    Ganguly, Sonali
    Finkelstein, Eric A.
    Goh, Su-Yen
    VALUE IN HEALTH, 2020, 23 (07) : 842 - 850
  • [50] Patient preferences regarding treatment options for Waldenstrom's macroglobulinemia: A discrete choice experiment
    Amaador, Karima
    Nieuwkerk, Pythia T.
    Minnema, Monique C.
    Kersten, Marie Jose
    Vos, Josephine M., I
    CANCER MEDICINE, 2023, 12 (03): : 3376 - 3386